FDA Drug Application (021320) for PLENAXIS by SPECIALITY EUROPEAN

Back to FDA Applications sponsored by SPECIALITY EUROPEAN

Application Number021320
Product Number001
FormINJECTABLE;INTRAMUSCULAR
Dosage100MG/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePLENAXIS
Active IngredientABARELIX



Back to FDA Applications sponsored by SPECIALITY EUROPEAN